Patient population	American Society of Hypertension guideline42	European Society of Hypertension/European Society of Cardiology guideline43
Black patients	CCB or thiazide diuretic	CCB or thiazide diuretic
Nonblack patients younger than 60 years	ARB or ACE inhibitor	CCB, thiazide diuretic, ARB, ACE inhibitor, or beta blocker
Nonblack patients 60 years and older	CCB, thiazide diuretic, ARB, or ACE inhibitor	CCB or thiazide diuretic
Patients with chronic kidney disease	ARB or ACE inhibitor	ARB or ACE inhibitor
Patients with coronary artery disease	Beta blocker and ARB or ACE inhibitor	Beta blocker, ARB, or ACE inhibitor
Patients with diabetes mellitus	ARB or ACE inhibitor (CCB or thiazide diuretic in black patients)	ARB or ACE inhibitor
Patients with heart failure	ARB or ACE inhibitor and beta blocker and spironolactone (Aldactone)	Thiazide diuretic, beta blocker, ARB, ACE inhibitor, or spironolactone
Patients with history of stroke	ARB or ACE inhibitor	CCB, thiazide diuretic, ARB, ACE inhibitor, or beta blocker